Agendia BV
Pharmacogenomics firm closes series A financing round
Published in Healthcare Mergers, Acquisitions and Ventures Week, May 1st, 2004
Global Life Science Ventures (Germany, Switzerland, U.K) and AXA Private Equity Venture Funds from France also participated in the investment consortium.
Agendia is a pharmacogenomics company founded recently by scientists from the Netherlands Cancer Institute (NKI) in Amsterdam who have developed the first microarray-based diagnostic test to predict the aggressiveness of breast cancer tumors based on the activity of key genes. The important discovery of a predictive breast cancer profile and its validation in an...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- AMDL, Inc.
Cancer diagnostics company reports 101% increase in revenue - Abortion
Doctor testifies that banned type of abortion needs more study - Adoption Issues
Oklahoma health department to issue birth certificates to same-sex couples - Alliance for Lupus Research
Lupus group announces $6.7M in research grants - Alta Partners
Venture capital fund closes $475M in life sciences funds - Alza Corp.
Mylan loses patent infringement suit - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
